RAMM Pharma Corp.
RAMM
CNSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 37.01% | 43.92% | 47.12% | -47.68% | -51.73% |
| Total Depreciation and Amortization | -52.32% | -46.55% | -41.14% | -24.52% | -14.87% |
| Total Amortization of Deferred Charges | 142.86% | 85.71% | 14.29% | -- | -- |
| Total Other Non-Cash Items | -45.21% | -55.30% | -55.32% | 169.57% | 171.04% |
| Change in Net Operating Assets | 4.11% | 38.25% | 76.84% | 2,811.64% | 292.14% |
| Cash from Operations | 35.03% | 63.46% | 74.39% | 67.24% | 42.10% |
| Capital Expenditure | -- | 141.12% | 100.00% | 72.13% | 48.03% |
| Sale of Property, Plant, and Equipment | 39.83% | -- | -- | 475.83% | 440.19% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -118.45% | -118.96% |
| Cash from Investing | 49.41% | 1,626.25% | 2,608.43% | 685.85% | 370.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 72.66% | 61.78% | 43.63% | 19.20% | -0.55% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -153.09% | -- | -- | 92.94% | 252.17% |
| Cash from Financing | 66.71% | 58.97% | 42.33% | 24.65% | 37.30% |
| Foreign Exchange rate Adjustments | -48.72% | -233.18% | -1,780.00% | -138.12% | -137.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 68.63% | 114.47% | 99.75% | 79.97% | 55.35% |